Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel free fatty acid FFA1 receptor agonists for diabetes claimed by Lilly

May 12, 2011

Takeda and Pronova report on pivotal Japanese trial of TAK-085 in hypertriglyceridemia

May 10, 2011

Compound 49b shows promise to treat diabetic retinopathy

May 10, 2011

European phase III Diamyd trial in type 1 diabetes does not meet primary endpoint

May 9, 2011

Dainippon Sumitomo Pharma sets Japanese launch date for Surepost

May 9, 2011

Zafgen claims novel methionine aminopeptidase 2 inhibitors

May 9, 2011

Pfizer discovers potent and selective inhibitors of phosphodiesterase 8B

May 9, 2011

Santaris Pharma advances SPC-5001 to phase I for hypercholesterolemia

May 6, 2011

Savient Pharmaceuticals files MAA with the EMA for Krystexxa in chronic gout

May 5, 2011

Novel estrogen receptor beta ligands prepared at Karo Bio

May 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...